The Muscle Mag
The firm announced the upcoming launch of Nextida, a comprehensive collection of specific compositions designed to provide unique health benefits. The first release will focus on glucose management.
“After extensive research on collagen molecules, Rousselot is excited to introduce Nextida, offering new health advantages beyond traditional collagen peptides. Nextida’s innovation lies in its targeted actions,” said Jeroen Colpaert, executive vice president at Rousselot.
Nextida.GC (glucose control) will be the initial specific collagen peptide from the Nextida platform, aiming to naturally reduce post-meal sugar spikes in healthy individuals.
Gaëtan Noiret, global director for health and nutrition, highlighted the increasing interest in glucose metabolism and blood sugar control.
“Currently, there are many solutions on the market, but none utilize collagen peptides,” Noiret informed NutraIngredients.
Scientific studies showcasing the impact of Nextida.GC on glucose metabolism will be presented at SupplySide West in Las Vegas in October 2024.
“We will unveil the mechanism of action at Supply Side West,” Noiret stated. “In technical studies, we observe the significant role of GLP-1 (glucagon-like peptide 1).”
Discussing Rousselot’s collagen Peptan line, he added that these products offer a variety of health benefits, including support for sleep and gut health, in addition to the usual benefits for skin and joint health, providing holistic health solutions.
Metabolic syndrome: ‘the next major pandemic’
During a presentation on metabolic syndrome at the Vitafoods symposium, Rick Miller, associate director of specialized nutrition at Mintel, stated, “We need to view metabolic syndrome as the next major pandemic.”
The key components of metabolic syndrome include obesity, high blood pressure, high blood triglycerides, low HDL cholesterol levels, and insulin resistance (glucose control).
The American Heart Association disclosed that one third of U.S. residents (34%) may be experiencing some level of metabolic dysfunction, as noted by Miller.
“The Harvard T.H. Chan School of Public Health suggests that lifestyle changes such as diet, exercise, and sleep could prevent diabetes,” he explained.
“Continuous monitoring of glucose levels, commonly associated with diabetes management, is extending beyond medical settings, though their accuracy compared to medical-grade devices is a subject of debate. Nonetheless, they offer valuable insights for consumers.”
